Evaluating a Physician Audit and Feedback Intervention to Increase Clinical Trial Enrollment in Radiation Oncology in

Nicholas P Verdini1, Daphna Y Gelblum1, Emily A Vertosick2

  • 1Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York.

Abstract

Insights

Physician audit and feedback reports did not significantly improve cancer clinical trial enrollment. Strategies should avoid discouraging high enrollers and may need to combine multiple approaches for better results.

Area of Science:

  • Oncology
  • Clinical Trials
  • Healthcare Quality Improvement

Background:

  • Low clinical trial participation hinders the development of new cancer therapies.
  • Prospective strategies to address enrollment barriers are infrequently tested.
  • Physician audit and feedback is a potential quality improvement method.

Purpose of the Study:

  • To investigate the effectiveness of physician audit and feedback reports in improving clinical trial enrollment rates.
  • To assess the impact of comparative performance data on physician trial recruitment.

Main Methods:

  • A randomized quality improvement study was conducted among radiation oncologists across a multisite cancer network.
  • Physicians in the intervention group received quarterly audit and feedback reports comparing their enrollment rates to peers.
  • The primary outcome measured was the proportion of patients enrolled in clinical trials.

Main Results:

  • The median enrollment proportion increased in both the feedback group (3.2% to 6.1%) and the control group (1.6% to 4.1%).
  • There was no significant change in enrollment associated with receiving feedback reports (-0.6% difference; P = .6).
  • An interaction effect (P = .005) indicated declining enrollment among high-accruing physicians in the feedback group.

Conclusions:

  • Physician audit and feedback alone did not demonstrate a positive effect on clinical trial enrollment.
  • Future interventions should consider strategies that do not disincentivize high-performing physicians.
  • Pairing feedback with other patient- or physician-level strategies may be more effective.

Related Concept Videos

Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.0K
Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
6.8K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
145
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
380